Relitect
Glasgow · Founded 2014
About Relitect
Relitect is developing a novel assay platform for the label free electrochemical detection of binding events. The company's proprietary technology can be applied for high sensitivity, multiplexed diagnostic and life science research products.
Company Facts
- Founded: 2014
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $1.1M
- Funding stage: Seed
- Last round: Seed (Mar 2015)
- Website: http://www.relitect.com/
- Phone: +44 (0) 1698 535260
Canonical: https://fsome.com/organization/relitect-8261036 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.